Sign in
4

Changes in Ownership

MoonLake Immunotherapeutics Filed Acc 0001213900-26-082804

Chief Scientific Officer sold 1,100 shares at $20.00 ($22,000)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Reich Kristian Chief Scientific Officer 2026-07-27 Sale 10b5-1 −1,100 $20.00 $22,000 2,711,198 I
Open-market sales · 1,100 sh · avg $20.00 · $22,000
Loading xslF345X06/ownership.xml…